Annual Secretarial Compliance Report for FY 2024-25.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bharat Parenterals has submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2025, as required by SEBI's listing rules. The report, certified by Jigar Trivedi & Co., confirms the company complied with most SEBI regulations on secretarial standards, insider trading, related party transactions, website disclosures, and board evaluations. One minor non-compliance was flagged: a four-day delay in filing the FY2023-24 Annual Report, for which BSE levied a fine of Rs. 4,720 (including tax), already paid. The statutory auditor M/s. CNK & Associates LLP resigned effective August 10, 2024, with all related disclosures properly made. No further action was taken by SEBI or stock exchanges against the company.
This is a routine annual compliance filing with no material concerns for shareholders. The fines paid are very small (a few thousand rupees) and the company has shown corrective care in the current year. No impact on stock price is expected.